SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-08-000623
Filing Date
2008-01-04
Accepted
2008-01-04 17:28:11
Documents
1
Period of Report
2008-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3906
  Complete submission text file 0001179110-08-000623.txt   5888
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001
PONIARD PHARMACEUTICALS, INC. (Issuer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O CELLEGY PHARMACEUTICALS INC 349 OYSTER POINT BLVD #200 S. SAN FRANCISCO CA 94080
Business Address 6506162200
KARLIN DAVID A (Reporting) CIK: 0001247409 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16614 | Film No.: 08512934